Clinical Trial Update: Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial compared pregabalin with paroxetine for management of neuropathic pain due to multiple sclerosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neuropathic Pain

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• Pregabalin (Pregabalin)

Snippet

Sponsor: University of Manitoba | Conditions: Neuropathic Pain, Multiple Sclerosis | Phase 3 | Status: COMPLETED